Literature DB >> 22903043

Structure-based drug design: Opening the door to an epigenetic target.

Charlotte Harrison.   

Abstract

Year:  2012        PMID： 22903043     DOI： 10.1038/nrd3827

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

Review 1.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

2.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response.

Authors:  Laurens Kruidenier; Chun-wa Chung; Zhongjun Cheng; John Liddle; KaHing Che; Gerard Joberty; Marcus Bantscheff; Chas Bountra; Angela Bridges; Hawa Diallo; Dirk Eberhard; Sue Hutchinson; Emma Jones; Roy Katso; Melanie Leveridge; Palwinder K Mander; Julie Mosley; Cesar Ramirez-Molina; Paul Rowland; Christopher J Schofield; Robert J Sheppard; Julia E Smith; Catherine Swales; Robert Tanner; Pamela Thomas; Anthony Tumber; Gerard Drewes; Udo Oppermann; Dinshaw J Patel; Kevin Lee; David M Wilson
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962
  2 in total
  1 in total

Review 1.  Hypoxia in Cell Reprogramming and the Epigenetic Regulations.

Authors:  Nariaki Nakamura; Xiaobing Shi; Radbod Darabi; Yong Li
Journal:  Front Cell Dev Biol       Date:  2021-01-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.